What is Certa Dose?
Certa Dose is dedicated to creating innovative dosing solutions aimed at eliminating medical dosing errors, particularly in pediatric care. Their product line includes the PALS Syringe Holder Kit and the Certa Dose App, which help healthcare professionals visualize accurate dosages and streamline the administration process. The company targets healthcare providers who deal with critical dosing situations, especially in emergency settings. By focusing on clarity and verification, Certa Dose enhances patient safety and confidence in medical emergencies. The company's approach to securing major enterprise-level funding, primarily through debt instruments, suggests a strategy focused on leveraging existing assets or cash flow to fuel growth without diluting equity, positioning it for significant operational scaling or strategic market penetration.
How much funding has Certa Dose raised?
Certa Dose has raised a total of $3.9M across 3 funding rounds:
Debt
$3.5M
Debt
$150K
Debt
$210K
Debt (2017): $3.5M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $210K supported by PPP
What's next for Certa Dose?
With substantial backing and a clear mission to combat medical dosing errors, Certa Dose is poised for significant expansion. The recent major strategic investment, likely aimed at scaling production and broadening market reach, suggests a focus on solidifying its position in the healthcare technology landscape. Future developments may involve further integration of their app and syringe holder technology into standard medical protocols, potentially leading to new partnerships and wider adoption across healthcare systems. The company's continued emphasis on patient safety and accuracy in dosing positions it as a key player in reducing adverse medical events.
See full Certa Dose company page
